Evidence map›Paper›PMID 39421268›Full record

ArticleBMJ public health2024

Effectiveness of direct patient outreach with a narrative naloxone and overdose prevention video to patients prescribed long-term opioid therapy in the USA: the Naloxone Navigator randomised clinical trial.

Jason M Glanz, Shane R Mueller, Komal J Narwaney, Nicole Wagner, Stan Xu, Courtney Kraus, Kris Wain, Sheila Botts, Ingrid A Binswanger

Registry-linked trialAbstract read
In one paragraph

Article in BMJ public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03337009 (The Impact of a Web-Based Naloxone Intervention Under Standing Orders to Patients Prescribed Chronic Opioid Therapy), which is not on this map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03337009 naunknown statusnot on this map

The Impact of a Web-Based Naloxone Intervention Under Standing Orders to Patients Prescribed Chronic Opioid Therapy

TypeinterventionalSponsorKaiser PermanenteRan2017 to 2024Enrolled1,004ConditionsOverdose, Risk BehaviorArmsNaloxone Navigator (NN)
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jason M GlanzInstitute for Health Research, Kaiser Permanente Colorado, Aurora, CO.
Shane R MuellerInstitute for Health Research, Kaiser Permanente Colorado, Aurora, CO.
Komal J NarwaneyInstitute for Health Research, Kaiser Permanente Colorado, Aurora, CO.
Nicole WagnerInstitute for Health Research, Kaiser Permanente Colorado, Aurora, CO.
Stan XuInstitute for Health Research, Kaiser Permanente Colorado, Aurora, CO.
Courtney KrausInstitute for Health Research, Kaiser Permanente Colorado, Aurora, CO.
Kris WainInstitute for Health Research, Kaiser Permanente Colorado, Aurora, CO.
Sheila BottsClinical Pharmacy Services, Kaiser Permanente Colorado, Aurora, CO.
Ingrid A BinswangerInstitute for Health Research, Kaiser Permanente Colorado, Aurora, CO.

Funding

NIH Prior Approval Process ProfessionalUL1TR002535 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2018 to 2022
$51.1M
The Safety and Impact of Expanded Access to Naloxone in Health SystemsR01DA042059 · NIDA · KAISER FOUNDATION RESEARCH INSTITUTE · PI BINSWANGER, INGRID A, GLANZ, JASON M · 2016 to 2020
$3.6M
Vending machine Naloxone Distribution for Your community (VENDY): Increasing reach and implementation of naloxone distributionK01DA056698 · NIDA · UNIVERSITY OF COLORADO DENVER · PI WAGNER, NICOLE MARIE · 2022 to 2025
$616k
NCATS NIH HHS UL1 TR002535NIDA NIH HHS K01 DA056698NIDA NIH HHS R01 DA042059
6 · The paper itself

Abstract

introductionPublic health efforts to reduce opioid overdose fatalities include educating people at risk and expanding access to naloxone, a medication that reverses opioid-induced respiratory depression. People receiving long-term opioid therapy (LTOT) are at increased risk for overdose, yet naloxone uptake in this population remains low. The objective of this study was to determine if a targeted, digital health intervention changed patient risk behavior, increased naloxone uptake, and increased knowledge about opioid overdose prevention and naloxone.

methodsWe conducted a pragmatic randomized clinical trial among patients prescribed LTOT in a health care delivery system in Colorado. Participants were randomly assigned to receive an animated overdose prevention and naloxone educational video (intervention arm) or usual care (control arm). The 6-minute video was designed to educate patients about opioid overdose and naloxone, increase overdose risk perception, and prompt them to purchase naloxone from the pharmacy. Over an 8-month follow-up, opioid risk behavior was assessed with the Opioid-Related Behaviors in Treatment survey instrument, and overdose and naloxone knowledge was measured with the Prescription Opioid Overdose Knowledge Scale after viewing the video at baseline. Naloxone dispensations were evaluated using pharmacy data over a 12-month period. Data were analyzed with generalized linear mixed effects and log-binomial regression models.

resultsThere were 519 participants in the intervention arm and 485 participants in the usual care arm. Opioid risk behavior did not differ between the study arms over time (study arm by time interaction P=0.93). There was no difference in naloxone uptake between the arms (RR = 1.13, 95% CI: 0.77-1.66). Knowledge was significantly greater in the intervention arm compared to usual care (P<0.001).

conclusionsA targeted, digital health intervention video effectively increased opioid overdose and naloxone knowledge, without increasing opioid risk behavior. Naloxone uptake did not differ between the intervention and usual care arms.

trial registrationClinicalTrials.gov number NCT03337009.

Indexed as

naloxoneopioidsoverdosepragmatic randomized clinical trial

Identifiers

PMID39421268
PMCPMC11485839

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.